Novo Holdings A/S’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Novo Holdings A/S’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,153,911	Closed	-$2.35M	–	50
2020 Q3	$2.35M	Sell	1,153,911 -1,027,932	-47%	-$2.93M	0.12%	42
2020 Q2	$6.46M	Hold	2,181,843	–	–	0.42%	29
2020 Q1	$5.76M	Hold	2,181,843	–	–	0.38%	20
2019 Q4	$10.8M	Hold	2,181,843	–	–	0.7%	18
2019 Q3	$13M	Hold	2,181,843	–	–	2.23%	10
2019 Q2	$14.1M	Hold	2,181,843	–	–	1.97%	13
2019 Q1	$14.7M	Hold	2,181,843	–	–	2.18%	11
2018 Q4	$8.88M	Hold	2,181,843	–	–	1.25%	13
2018 Q3	$23.7M	Buy	+2,181,843	New	+$22.9M	1.88%	9

Other funds holding ETTX

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Novo Holdings A/S's ETTX Position: Q4 2020 in Review

Novo Holdings A/S sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2020, closing a stake of 1,153,911 shares — an estimated $2.35M sold.

Novo Holdings A/S first reported a position in ETTX in Q3 2018 and held it in 9 quarters. The position peaked at $23.7M in Q3 2018. 25 funds tracked by Wall St. Rank hold ETTX as of Q4 2020.

Novo Holdings A/S reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2020 after selling out during the quarter.
Novo Holdings A/S sold 1,153,911 Entasis Therapeutics Holdings Inc. shares in Q4 2020, an estimated $2.35M.
Novo Holdings A/S first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2018 and held it in 9 quarters.
Novo Holdings A/S's Entasis Therapeutics Holdings Inc. position peaked at $23.7M in Q3 2018.
25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2020.

Based on Novo Holdings A/S's 13F filing for Q4 2020, filed 16 Feb 2021.